Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Opens Gene Expression Profiling Facility

NEW YORK, December 14 - Rosetta Inpharmatics inaugurated Thursday a new gene
expression profiling facility in Bothell, Wash.

At the facility, researchers will use image analysis technology and
molecular biology processes to generate gene expression data for drug and
drug target discovery, the company said.

" Our new facility in Bothell will help us further our efforts in gene
expression research, and will advance our goal to develop solutions that
will accelerate and enhance the drug discovery process," said Rosetta CEO
Stephen Friend in a statement.

On November 30, Rosetta announced it would jointly develop a gene expression
toxicity database with Abbott labs. Rosetta has announced other gene
expression profiling collaborations with Monsanto and Gemini Genomics.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.